Class information for:
Level 1: ETS 1//ETS1//ETS

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
6850 1436 46.4 92%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
455 3       HEMOGLOBIN//SICKLE CELL DISEASE//SICKLE CELL ANEMIA 25359
1216 2             PU1//ETS 1//GATA 1 9149
6850 1                   ETS 1//ETS1//ETS 1436

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 ETS 1 authKW 1406896 8% 56% 119
2 ETS1 authKW 372344 3% 49% 36
3 ETS authKW 344768 7% 17% 97
4 ETS TRANSCRIPTION FACTOR authKW 326622 3% 39% 39
5 ETS DOMAIN authKW 284129 1% 64% 21
6 ETS FAMILY authKW 274122 1% 68% 19
7 PEA3 authKW 229217 2% 37% 29
8 FLI 1 authKW 222229 2% 37% 28
9 E1AF authKW 208364 1% 70% 14
10 C ETS1 authKW 204115 1% 80% 12

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 Cell Biology 5725 33% 0% 473
2 Oncology 4946 31% 0% 449
3 Biochemistry & Molecular Biology 4559 47% 0% 680
4 Genetics & Heredity 2422 18% 0% 259
5 Developmental Biology 620 5% 0% 65
6 Hematology 239 5% 0% 68
7 Biophysics 180 5% 0% 74
8 Pathology 146 4% 0% 51
9 Immunology 90 6% 0% 82
10 Virology 32 2% 0% 24

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 UMR 8526 CNRS 63788 0% 100% 3
2 FUNCT GENOM HUMAN DIS 54812 1% 18% 14
3 NEUROSCI CHINESE PLA 47839 0% 75% 3
4 UMR 8526 43377 1% 20% 10
5 DEV GENET FOCUS GRP 42525 0% 100% 2
6 MEDNEW ENGLAND B TIST BONE JOINT 42525 0% 100% 2
7 BIOL LILLE 40718 2% 8% 25
8 HOLLINGS CANC 40301 3% 5% 39
9 CNRS URA 1160 38270 0% 60% 3
10 CNRSUMR 8117 38270 0% 60% 3

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 ONCOGENE 24035 10% 1% 143
2 ONCOGENE RESEARCH 5906 0% 4% 7
3 MOLECULAR AND CELLULAR BIOLOGY 4464 5% 0% 69
4 CRITICAL REVIEWS IN ONCOGENESIS 2589 0% 3% 4
5 JOURNAL OF BIOLOGICAL CHEMISTRY 1435 7% 0% 106
6 CELL GROWTH & DIFFERENTIATION 952 1% 1% 8
7 NUCLEIC ACIDS RESEARCH 882 3% 0% 42
8 INTERNATIONAL JOURNAL OF ONCOLOGY 859 1% 0% 20
9 MECHANISMS OF DEVELOPMENT 806 1% 0% 11
10 HYBRIDOMA 803 1% 0% 9

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
LCSH search Wikipedia search
1 ETS 1 1406896 8% 56% 119 Search ETS+1 Search ETS+1
2 ETS1 372344 3% 49% 36 Search ETS1 Search ETS1
3 ETS 344768 7% 17% 97 Search ETS Search ETS
4 ETS TRANSCRIPTION FACTOR 326622 3% 39% 39 Search ETS+TRANSCRIPTION+FACTOR Search ETS+TRANSCRIPTION+FACTOR
5 ETS DOMAIN 284129 1% 64% 21 Search ETS+DOMAIN Search ETS+DOMAIN
6 ETS FAMILY 274122 1% 68% 19 Search ETS+FAMILY Search ETS+FAMILY
7 PEA3 229217 2% 37% 29 Search PEA3 Search PEA3
8 FLI 1 222229 2% 37% 28 Search FLI+1 Search FLI+1
9 E1AF 208364 1% 70% 14 Search E1AF Search E1AF
10 C ETS1 204115 1% 80% 12 Search C+ETS1 Search C+ETS1

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref. in
cl.
Shr. of ref. in
cl.
Citations
1 DITTMER, J , (2015) THE ROLE OF THE TRANSCRIPTION FACTOR ETS1 IN CARCINOMA.SEMINARS IN CANCER BIOLOGY. VOL. 35. ISSUE . P. 20 -38 168 54% 4
2 SETH, A , WATSON, DK , (2005) ETS TRANSCRIPTION FACTORS AND THEIR EMERGING ROLES IN HUMAN CANCER.EUROPEAN JOURNAL OF CANCER. VOL. 41. ISSUE 16. P. 2462-2478 106 65% 243
3 GARRETT-SINHA, LA , (2013) REVIEW OF ETS1 STRUCTURE, FUNCTION, AND ROLES IN IMMUNITY.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 70. ISSUE 18. P. 3375 -3390 91 59% 22
4 REMY, P , BALTZINGER, M , (2000) THE ETS-TRANSCRIPTION FACTOR FAMILY IN EMBRYONIC DEVELOPMENT: LESSONS FROM THE AMPHIBIAN AND BIRD.ONCOGENE. VOL. 19. ISSUE 55. P. 6417-6431 126 66% 27
5 HAHNE, JC , OKUDUCU, AF , SAHIN, A , FAFEUR, V , KIRIAKIDIS, S , WERNERT, N , (2008) THE TRANSCRIPTION FACTOR ETS-1: ITS ROLE IN TUMOUR DEVELOPMENT AND STRATEGIES FOR ITS INHIBITION.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 8. ISSUE 11. P. 1095-1105 114 53% 19
6 HOLLENHORST, PC , MCINTOSH, LP , GRAVES, BJ , (2011) GENOMIC AND BIOCHEMICAL INSIGHTS INTO THE SPECIFICITY OF ETS TRANSCRIPTION FACTORS.ANNUAL REVIEW OF BIOCHEMISTRY, VOL 80. VOL. 80. ISSUE . P. 437-471 93 41% 150
7 OLIVER, JR , KUSHWAH, R , HU, J , (2012) MULTIPLE ROLES OF THE EPITHELIUM-SPECIFIC ETS TRANSCRIPTION FACTOR, ESE-1, IN DEVELOPMENT AND DISEASE.LABORATORY INVESTIGATION. VOL. 92. ISSUE 3. P. 320 -330 59 84% 18
8 KAR, A , GUTIERREZ-HARTMANN, A , (2013) MOLECULAR MECHANISMS OF ETS TRANSCRIPTION FACTOR-MEDIATED TUMORIGENESIS.CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY. VOL. 48. ISSUE 6. P. 522-543 99 45% 28
9 WASYLYK, B , HAHN, SJL , GIOVANE, A , (1993) THE ETS FAMILY OF TRANSCRIPTION FACTORS.EUROPEAN JOURNAL OF BIOCHEMISTRY. VOL. 211. ISSUE 1-2. P. 7-18 79 57% 777
10 DE LAUNOIT, Y , BAERT, JL , CHOTTEAU-LELIEVRE, A , MONTE, D , COUTTE, L , MAUEN, S , FIRLEJ, V , DEGERNY, C , VERRERNAN, K , (2006) THE ETS TRANSCRIPTION FACTORS OF THE PEA3 GROUP: TRANSCRIPTIONAL REGULATORS IN METASTASIS.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1766. ISSUE 1. P. 79 -87 71 70% 63

Classes with closest relation at Level 1



Rank Class id link
1 19585 PU1//SFPI1 PU1//RADIATION INDUCED AML
2 34876 GLIOBLASTOMA CELL STRAIN//UPA PROMOTER//CELL CYCLE PREVALENCE
3 10638 SERUM RESPONSE FACTOR//MYOCARDIN//SRF
4 31160 VB 111//MOL VASC MED//ADV STUDIES PHARMACOBIOL
5 9279 C MYB//B MYB//MYB
6 8778 PCA3//TMPRSS2 ERG//PROSTATE CANCER ANTIGEN 3
7 37328 ACTIVATION MECHANISMS AND REGULATION//ADAPTIVE RANDOM SEARCH TECHNIQUE//AGONISTIC ANTAGONISTIC MODELS
8 14203 GATA 1//GATA2//EDAG
9 36779 CDK11P58//PITSLRE//CDK11
10 1095 EWINGS SARCOMA//EWING SARCOMA//PRIMITIVE NEUROECTODERMAL TUMOR

Go to start page